Search results
30 kwi 2019 · Although surgery and Mohs micrographic surgery are often considered the optimal treatment options for basal cell carcinoma, these tumors can also be treated successfully with destructive techniques (eg, curettage alone, cryosurgery, or electrodesiccation), photodynamic therapy, topical drugs (eg, 5-fluorouracil, imiquimod, or ingenol mebutate ...
- Update on the Management of Basal Cell Carcinoma - PMC
The standard treatment for most basal cell carcinomas is...
- Update on the Management of Basal Cell Carcinoma - PMC
1 paź 2021 · The goal of treatment for basal cell carcinoma is to remove the cancer completely. Which treatment is best for you depends on the type, location and size of your cancer, as well as your preferences and ability to do follow-up visits.
What is the treatment for advanced or metastatic basal cell carcinoma? Locally advanced primary, recurrent or metastatic BCC requires multidisciplinary consultation. Often a combination of treatments is used. Surgery; Radiotherapy; Targeted therapy. Targeted therapy refers to the hedgehog signalling pathway inhibitors, vismodegib and sonidegib ...
18 cze 2019 · Topical therapies (5% imiquimod, 5% fluorouracil) and destructive approaches (curettage, electrocautery, cryotherapy, laser ablation) should be considered in patients with low-risk superficial BCC. Photodynamic therapy is an effective treatment for superficial BCC and thin nodular BCC.
3 cze 2020 · The standard treatment for most basal cell carcinomas is surgery, as it allows excision margin control and shows a low risk of recurrence. Superficial lesions can be treated by non-surgical methods with significant efficacy. Key words: basal cell carcinoma, treatment, prognosis, surgery, radiotherapy, hedgehog inhibitors.
3 lut 2015 · Early treatment of BCC is curative in the vast majority of cases, thus preventing progression with local approaches such as surgical excision, radiotherapy, topical imiquimod, or photodynamic therapy [4]. The likelihood of recurrence following treatment is used to categorize lesions as low or high risk.
Topical therapies (5% imiquimod, 5% fluorouracil) and destructive approaches (curet-tage, electrocautery, cryotherapy, laser ablation) should be considered in patients with low-risk superficial BCC. Photodynamic therapy is an effective treatment for superficial BCC and thin nodular BCC.
